Maternal and Child Health Journal

, Volume 16, Issue 5, pp 1113–1119 | Cite as

Obstetric Providers’ Knowledge, Awareness, and Use of CDC’s HIV Testing Recommendations and One Test. Two Lives.

  • Donata R. Green
  • Britta L. Anderson
  • Michael F. Burke
  • Judith Griffith
  • Jay Schulkin
Article

Abstract

This study examined the impact of the Centers for Disease Control and Prevention’s (CDC’s) One Test. Two Lives.™ (OTTL) campaign on key outcomes related to CDC’s revised HIV testing recommendations and the use of the campaign materials. Data from three cross-sectional surveys were used to assess the effect of OTTL on Obstetricians/Gynecologists’ (OB/GYN) HIV knowledge and practice. A 2-year combined sample of 500 OB/GYNs completed DocStyles, a Web-based survey for physicians, and 575 American College of Obstetricians and Gynecologists (ACOG) Fellows completed an ACOG survey. The surveys were similar in focus but did not contain the same items. Data were analyzed using cross-tabulations, χ2 analyses, and logistic regression. There was a 20% recall of exposure to OTTL with DocStyles and 25% with ACOG. DocStyles respondents reporting having seen OTTL materials were significantly more likely to report awareness of CDC’s recommendations [χ2(1) = 25.43, P < .001] and include HIV testing as a regular screening test for all patients [χ2(1) = 4.98, P < .05]. ACOG respondents not using the materials indicated high levels of willingness to use the materials—63.0 to 71.5%, depending on the material. Of the ACOG sample, 68.1% correctly answered the knowledge items regarding the recommendations. However, a significant relationship between correct knowledge and campaign exposure was not found. Overall, results suggest that OTTL is instrumental in raising awareness and implementation of the testing recommendations and plays an important role in facilitating HIV testing practices with obstetric providers and their patients.

Keywords

One Test. Two Lives.™ Prenatal CDC HIV testing recommendations HIV prevention materials Perinatal HIV transmission ACOG Committee Opinion #418 Communication campaign 

Notes

Acknowledgments

We would like to thank Laura McElroy (CDC) for her input in the beginning stages of this project and Dr. Jo Ellen Stryker (CDC) and Rebecca Carlson (ACOG) for their insightful feedback on manuscript drafts. This study was funded in part by grant, UA6MC19010, through the U.S. Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Research Programs. The findings and discussion in the paper are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

References

  1. 1.
    Centers for Disease Control and Prevention. (2008). HIV prevelence estimates—United States, 2006. Morbidity and Mortality Weekly Report, 57(39), 1073–1076. Available at http://www.cdc.gov/hiv/resources/reports/hiv_prev_us.htm.
  2. 2.
    Centers for Disease Control and Prevention (CDC). (2008). Enhanced perinatal surveillance—Participating areas in the United States and dependent areas, 2000–2003. In HIV/AIDS surveillance supplemental report, No. 4. Atlanta: U.S. Department of Health and Human Services p. 14. Available at http://www.cdc.gov/hiv/topics/surveillance/resources/reports/#supplemental.
  3. 3.
    Cooper, E. R., et al. (2002). Combination antiretroviral strategies for the treatment of pregnant HIV-1–infected women and prevention of perinatal HIV-1 transmission. Journal of AIDS, 295, 484–494.Google Scholar
  4. 4.
    Connor, E. M., et al. (1994). Reduction of maternal-infant transmission of Human-Immunodeficiency-Virus type-1 with zidovudine treatment. New England Journal of Medicine, 331(18), 1173–1180.PubMedCrossRefGoogle Scholar
  5. 5.
    Wade, N. A., et al. (1998). Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. New England Journal of Medicine, 339(20), 1409–1414.PubMedCrossRefGoogle Scholar
  6. 6.
    Branson, B., et al. (2006). Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. Morbidity and Mortality Weekly Report, 55(RR14), 1–17.Google Scholar
  7. 7.
    American College of Obstetricians and Gynecologists. (2008). Prenatal and perinatal Human Immunodeficiency Virus testing: Expanded recommendations. ACOG Committee Opinion 418. Obstetrics and Gynecology, 112(3), 739–742.Google Scholar

Copyright information

© Springer Science+Business Media, LLC (outside the USA)  2011

Authors and Affiliations

  • Donata R. Green
    • 1
  • Britta L. Anderson
    • 2
  • Michael F. Burke
    • 3
  • Judith Griffith
    • 1
  • Jay Schulkin
    • 2
  1. 1.Centers for Disease Control and Prevention (CDC)AtlantaUSA
  2. 2.Research Department, American College of Obstetricians and Gynecologists (ACOG)WashingtonUSA
  3. 3.RTI InternationalWashingtonUSA

Personalised recommendations